C O R P O R AT E O V E R V I E W THE FUTURE OF CLINICAL DEVELOPMENT PRA Health Sciences (PRA) provides innovative drug development solutions across all phases and therapeutic areas. But innovation just for the sake of innovation isn’t why we do it. Side-by-side with our clients, we strive to move drug discovery forward, to help them develop life-saving and life-improving drugs. We help change people’s lives for the better every day. It’s who we are. Innovating to help people is at the heart of our process, but it’s even more than that. It’s also our privilege. EXPERIENCE EXPERTISE N o . O F COU NTRI E S WI TH CO V E R A GE 80+ 10,000+ 3,300+ When a sponsor chooses you to help develop one of its promising compounds, it’s a compliment laden with great responsibility. At PRA, we understand and embrace that responsibility, having worked on 100+ marketed drugs across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of 50+ such drugs. Neurology & Psychiatry Gastroenterology 3 Infectious Diseases Genitourinary 3 4 Immunology 5 7 12 16 N o . O F E MP LOY E E S CardioMetabolic Oncology & Hematology Respiratory 3 Diagnostics 2 N o . O F CL I NI CA L STU D I ES * COMPREHENSIVE PHASE I-IV DRUG DEVELOPMENT * O VER TH E PA S T 5 YEA R S TECHNOLOGY EMPOWERS US TO CONNECT INSIGHTS AND MOVE IN ANY DIRECTION. ESPECIALLY FORWARD. 2 Bioanalytical Laboratories Strategic Solutions US and EU Staff Augmentation FSP Embedded Solutions 8 Clinical Pharmacology Units Post-Marketing Research Clinical Development 6 Global Drug Safety Centers 3 in the US 5 in the EU Phase II-III Studies “It isn’t enough to just be in multiple regions. Your project teams need to know how to harness this knowledge and to use it to make quality decisions that are aligned with the study goals.” SEAN LEECH, Executive Vice President, Product Registration (Europe, Asia Pacific, and Africa) PRA OFFICES PRA COVERAGE Tailored Approach to Real-world Research PRA’s operational model encourages employees to initiate creative solutions to keep projects on track when they encounter the need. It’s this culture of flexibility and support that enables us to search for the right answer to any given problem, and to be able to utilize those answers in providing better solutions for our clients. The story of PRA Health Sciences would naturally talk about how we’ve become one of the world’s largest CROs. It would talk about our innovation and growth and would speak to our operational efficiencies and transparency. It would highlight our expertise and customization. And it would touch on the incredible differences we’ve made, over our more than 30 years, in helping to bring to market everything from niche treatments and therapies to blockbuster drugs. More than anything else, our story would be about people. Not only our over 10,000 employees operating in more than 80 countries, though they’d certainly be a big part of it, but also the people that inspire them. The heroes of any PRA Health Sciences story are the clients we serve and the people whose lives we help improve, all over the world. And our story has only just begun. PRA PRA Health Health Sciences Sciences conducts conducts comprehensive comprehensive Phase phase I-IV I-IV biopharmaceutical biopharmaceutical drug drug development. development. To To learn learn more more about about our our solutions, solutions, please please visit visit us us at at prahs.com prahs.com or or email email us us at at [email protected]. [email protected].
© Copyright 2024 ExpyDoc
